Search

Find exactly what you’re looking for.
Search

Service
Showing 21-40 of 91 results
BACKGROUND: The Rule - What It Means and What It Prohibits A somewhat little-known and obscure provision of U.S. antitrust law – Section 8 of the Clayton Act – makes it illegal in certain circumstances for the same person to serve as a director of competing corporations. If certain conditions exist...
LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...

Kathryn Doyle, Partner at Saul Ewing LLP, will be presenting at the NACUA Annual Meeting, June 26-29, 2022, in Pittsburgh. She will be speaking on June 28, 9:15-10:30 a.m., on the topic "You Thought You Owned It, They Might Have Stolen It, and a Medley of Inventor Kerfuffles”. Joining Kathryn will...

George E. Rahn, Jr.

George "Ned" Rahn focuses his practice on commercial litigation including national and international construction matters. He has handled matters for contractors, engineering firms, owners, and surety bond companies in a variety of contexts. Ned has dealt with matters for general contractors...

Charles O. Monk, II

Charlie Monk handles complex, high-stakes litigation. During his 40 years as a trial lawyer, clients ranging from governmental entities and security broker dealers to energy providers and utilities have relied on his legal counsel to help them deal with complex litigation. He has led teams dealing...

Companies planning to develop and commercialize medical devices or diagnostics face a challenging financing, regulatory, reimbursement and liability environment. Saul Ewing attorneys are experienced in helping medical device and diagnostic companies navigate these challenges. Many members of our...

Jessica Lenoir

Jessica Lenoir, Ph.D., helps clients protect their intellectual property by drafting patent applications and preparing office action responses to the U.S. Patent and Trademark Office and foreign offices. In handling this work, Jessica draws on her knowledge from earning a doctorate in...

Stephanie Denker Headshot

Stephanie Denker focuses on complex commercial litigation, including insurance and securities law. In the Insurance industry, Stephanie has experience in lapse litigation, primarily in New York. Stephanie also defends insurance companies in class actions, including cases brought in Illinois, Florida...

Michael A. Finio

Mike Finio helps companies sort through antitrust and competition-related issues posed by federal and state antitrust law, the government regulatory and litigation-based enforcement that arises from it, and private antitrust activity. Mike's representation of publicly and privately held businesses...

John P. Englert

John P. Englert has almost 40 years of diverse environmental experience. Since 1994 John has practiced environmental law and before that he was an environmental consultant. In both capacities, he has served national and international companies in the energy, environmental and manufacturing sectors...

Government is growing every day. Regardless of which political party is in power, the scope of government regulation at the state, county and local levels, and the impact of government on all types of business has regularly increased. Regardless of your type of business – manufacturing or finance...

Protecting the Rights of Corporate Clients Companies generally enjoy a fruitful relationship with their shareholders, but disagreements about management, perceptions of minority shareholder mistreatment, or concerns over executive compensation may arise. No matter the cause of shareholder...

A key component of a company’s intellectual property strategy is the protection of its industrial designs, including the ornamental features of products, graphical user interfaces, icons and fonts, to combat competitors copying its products. Industrial design protection fills a niche between (and...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...

For More Information
Contact us